T Cell Islet Accumulation in Type 1 Diabetes Is a Tightly Regulated, Cell-Autonomous Event

Immunity

Volumn 31, Issue 4, 2009, Pages 643-653

  Lennon, Greig P ^a   Bettini, Maria ^a   Burton, Amanda R ^a   Vincent, Erica ^a   Arnold, Paula Y ^a   Santamaria, Pere ^b   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

CELLIMMUNO

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; GENE TRANSFER TECHNIQUES; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS;

EID: 70349745490     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.07.008     Document Type: Article

References (31)

1. Arnold P.Y., La Gruta N.L., Miller T., Vignali K.M., Adams P.S., Woodland D.L., and Vignali D.A. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 169 (2002) 739-749
2. Arnold P.Y., Burton A.R., and Vignali D.A. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. J. Immunol. 173 (2004) 3103-3111
3. Bridgett M., Cetkovic-Cvrlje M., O'Rourke R., Shi Y., Narayanswami S., Lambert J., Ramiya V., Baekkeskov S., and Leiter E.H. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta-cells. Diabetes 47 (1998) 1848-1856
4. Burton A.R., Vincent E., Arnold P.Y., Lennon G.P., Smeltzer M., Li C.S., Haskins K., Hutton J., Tisch R.M., Sercarz E.E., et al. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57 (2008) 1321-1330
5. Cantagrel A., Lambert N., and Alam A. T cell receptor gene in synovial tissues of rheumatoid arthritis. Int. Rev. Immunol. 17 (1998) 323-337
6. Carvalho-Pinto C., Garcia M.I., Gomez L., Ballesteros A., Zaballos A., Flores J.M., Mellado M., Rodriguez-Frade J.M., Balomenos D., and Martinez A. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur. J. Immunol. 34 (2004) 548-557
7. Chaparro R.J., Burton A.R., Serreze D.V., Vignali D.A., and DiLorenzo T.P. Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. J. Immunol. Methods 335 (2008) 106-115
8. Christen U., Benke D., Wolfe T., Rodrigo E., Rhode A., Hughes A.C., Oldstone M.B., and von Herrath M.G. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 113 (2004) 74-84
9. Delovitch T.L., and Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 7 (1997) 727-738
10. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., and Serreze D.V. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95 (1998) 12538-12543
11. Gonzalez A., Katz J.D., Mattei M.G., Kikutani H., Benoist C., and Mathis D. Genetic control of diabetes progression. Immunity 7 (1997) 873-883
12. Hamilton-Williams E.E., Palmer S.E., Charlton B., and Slattery R.M. Beta cell MHC class I is a late requirement for diabetes. Proc. Natl. Acad. Sci. USA 100 (2003) 6688-6693
13. Han B., Serra P., Amrani A., Yamanouchi J., Maree A.F., Edelstein-Keshet L., and Santamaria P. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: High efficiency of a low-affinity peptide. Nat. Med. 11 (2005) 645-652
14. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: More lessons from the NOD mouse. Adv. Immunol. 87 (2005) 123-162
15. Hill N.J., Van G.K., and Sarvetnick N. Th1 and Th2 pancreatic inflammation differentially affects homing of islet-reactive CD4 cells in nonobese diabetic mice. J. Immunol. 170 (2003) 1649-1658
16. Holst J., Szymczak-Workman A.L., Vignali K.M., Burton A.R., Workman C.J., and Vignali D.A. Generation of T-cell receptor retrogenic mice. Nat. Protocols 1 (2006) 406-417
17. Holst J., Vignali K.M., Burton A.R., and Vignali D.A. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat. Methods 3 (2006) 191-197
18. Kedzierska K., Turner S.J., and Doherty P.C. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc. Natl. Acad. Sci. USA 101 (2004) 4942-4947
19. Kim J., Richter W., Aanstoot H.J., Shi Y., Fu Q., Rajotte R., Warnock G., and Baekkeskov S. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 42 (1993) 1799-1808
20. Lieberman S.M., and DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 62 (2003) 359-377
21. Morimoto J., Yoneyama H., Shimada A., Shigihara T., Yamada S., Oikawa Y., Matsushima K., Saruta T., and Narumi S. CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis. J. Immunol. 173 (2004) 7017-7024
22. Pauza M.E., Dobbs C.M., He J., Patterson T., Wagner S., Anobile B.S., Bradley B.J., Lo D., and Haskins K. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 53 (2004) 978-988
23. Peterson J.D., Berg R., Piganelli J.D., Poulin M., and Haskins K. Analysis of leukocytes recruited to the pancreas by diabetogenic T cell clones. Cell. Immunol. 189 (1998) 92-98
24. Rhode A., Pauza M.E., Barral A.M., Rodrigo E., Oldstone M.B., von Herrath M.G., and Christen U. Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. J. Immunol. 175 (2005) 3516-3524
25. Schmidt D., Verdaguer J., Averill N., and Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186 (1997) 1059-1075
26. Sercarz E.E. Driver clones and determinant spreading. J. Autoimmun. 14 (2000) 275-277
27. Suri A., Shimizu J., Katz J.D., Sakaguchi S., Unanue E.R., and Kanagawa O. Regulation of autoimmune diabetes by non-islet-specific T cells-a role for the glucocorticoid-induced TNF receptor. Eur. J. Immunol. 34 (2004) 447-454
28. Szymczak A.L., Workman C.J., Wang Y., Vignali K.M., Dilioglou S., Vanin E.F., and Vignali D.A. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22 (2004) 589-594
29. Wen L., Wong F.S., Burkly L., Altieri M., Mamalaki C., Kioussis D., Flavell R.A., and Sherwin R.S. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. J. Clin. Invest. 102 (1998) 947-957
30. Xie J.H., Nomura N., Lu M., Chen S.L., Koch G.E., Weng Y., Rosa R., Di S.J., Mudgett J., Peterson L.B., et al. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J. Leukoc. Biol. 73 (2003) 771-780
31. Yamanouchi J., Verdaguer J., Han B., Amrani A., Serra P., and Santamaria P. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens. J. Immunol. 171 (2003) 6900-6909